Sebastiani, M., Lepri, G., Iannone, C., Cassione, E. B., Guggino, G., Lo Monaco, A., . . . Manfredi, A. (2025). Nintedanib in Rheumatoid Arthritis-Related Interstitial Lung Disease: Real-World Safety Profile and Risk of Side Effects and Discontinuation. Journal of rheumatology, 52(5), 420. https://doi.org/10.3899/jrheum.2024-0976
Citácia podle Chicago (17th ed.)Sebastiani, Marco, et al. "Nintedanib in Rheumatoid Arthritis-Related Interstitial Lung Disease: Real-World Safety Profile and Risk of Side Effects and Discontinuation." Journal of Rheumatology 52, no. 5 (2025): 420. https://doi.org/10.3899/jrheum.2024-0976.
Citácia podľa MLA (8th ed.)Sebastiani, Marco, et al. "Nintedanib in Rheumatoid Arthritis-Related Interstitial Lung Disease: Real-World Safety Profile and Risk of Side Effects and Discontinuation." Journal of Rheumatology, vol. 52, no. 5, 2025, p. 420, https://doi.org/10.3899/jrheum.2024-0976.